A Neuro-oncologist’s Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer

Management of non-small cell lung cancer (NSCLC) with brain metastasis (BrM) has been revolutionized by identification of molecular subsets that have targetable oncogenes. Historically, survival for NSCLC with symptomatic BrM was weeks to months. Now, many patients are surviving years with limited d...

Descripción completa

Detalles Bibliográficos
Autores principales: McGranahan, Tresa, Nagpal, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Lung Cancer (HA Wakelee, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385200/
https://www.ncbi.nlm.nih.gov/pubmed/28391420
http://dx.doi.org/10.1007/s11864-017-0466-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385200/
https://www.ncbi.nlm.nih.gov/pubmed/28391420
http://dx.doi.org/10.1007/s11864-017-0466-0

Ejemplares similares